WallStreetZenWallStreetZen

NASDAQ: CAPR
Capricor Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CAPR past revenue growth

How has CAPR's revenue growth performed historically?
Company
886.81%
Industry
144.63%
Market
17.55%
CAPR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CAPR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CAPR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CAPR earnings and revenue history

Current Revenue
$25.2M
Current Earnings
-$22.3M
Current Profit Margin
-88.5%

CAPR Return on Equity

Current Company
-299.7%
Current Industry
-63.5%
Current Market
188%
CAPR's Return on Equity (-299.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CAPR announces earnings.

CAPR Return on Assets

Current Company
-45.5%
Current Industry
2.9%
CAPR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CAPR Return on Capital Employed

Current Company
-81.15%
Current Industry
19.5%
CAPR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CAPR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CAPR$25.18M-$21.22M-$22.29M+72.02%N/A
CGEN$33.46MN/A-$18.75M+13.45%N/A
IVA$25.18M-$109.06M-$120.03M+24.86%N/A
GLSI$0.00-$8.89M-$8.89MN/AN/A
MDWD$18.69M-$3.34M-$6.72M+40.60%N/A
View Top Biotech Stocks

CAPR earnings dates

Next earnings date
May 14, 2024

Capricor Therapeutics Earnings & Revenue FAQ

What were CAPR's earnings last quarter?

On Invalid Date, Capricor Therapeutics (NASDAQ: CAPR) reported Q4 2023 earnings per share (EPS) of $0.02, up 106.45% year over year. Total Capricor Therapeutics earnings for the quarter were -$762.09 thousand. In the same quarter last year, Capricor Therapeutics's earnings per share (EPS) was -$0.31.

If you're new to stock investing, here's how to buy Capricor Therapeutics stock.

What was CAPR's earnings growth in the past year?

As of Q2 2024, Capricor Therapeutics's earnings has grown year over year. Capricor Therapeutics's earnings in the past year totalled -$22.29 million.

What is CAPR's earnings date?

Capricor Therapeutics's earnings date is Invalid Date. Add CAPR to your watchlist to be reminded of CAPR's next earnings announcement.

What was CAPR's revenue last quarter?

On Invalid Date, Capricor Therapeutics (NASDAQ: CAPR) reported Q4 2023 revenue of $12.09 million up 1,159.3% year over year. In the same quarter last year, Capricor Therapeutics's revenue was $959.90 thousand.

What was CAPR's revenue growth in the past year?

As of Q2 2024, Capricor Therapeutics's revenue has grown 886.81% year over year. This is 742.18 percentage points higher than the US Biotechnology industry revenue growth rate of 144.63%. Capricor Therapeutics's revenue in the past year totalled $25.18 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.